Number of incidents of non-compliance associated with water quality permits, standards and regulations
Unit
i
The unit(s) of measurement applicable to the metric.
: Number (#)
Indicator
i
Indicators were developed by WBCSD. Learn more on the Methodology page.
: Compliance with regulations and standards
Metric type
i
The category of nature-related metrics. Learn more on the Methodology page.
: Response
Framework alignment notes
i
The details of a metric’s alignment to each framework, including where the same or similar metric can be found within the listed framework.
ESRS E2-4 AR 25b
TNFD BP.C2.2
GRI 303-4-d
Refer to AMR's Industry Alliance Framework for alignment to metric
WHO Guidance
GBF Target 7, Target 14
Target example
i
An example target and the target source are presented to illustrate how a target could be set for this metric. Learn more on the Methodology page.
[Company name] will maintain zero incidents of non-compliance with water permits, standards, and regulations annually
Target source: WBCSD target template
Sector
i
Each metric applies to one sector.
Pharmaceutical
Value chain stage
i
Each metric applies to one or more stages of the value chain aligned with the associated actions.
Raw MaterialsManufacturingEnd of Life
Metric assessment
i
The relevance and feasibility scores were determined by WBCSD member companies. Learn more on the Methodology page.
Relevance:High
Feasibility:High
Related actions
i
The other actions that the metric is mapped to.
Reduce water use and wastage, particularly in water-stressed areas
Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites
Reduce air, water and soil pollution (including non-GHG emissions) from agriculture-related pharmaceutical manufacturing feedstocks by engaging with suppliers and encouraging the adoption of less polluting methods in alignment with a Science Based Targets Network (SBTN) Landscape Engagement Target
Reduce APIs (including antibiotics) in the environment by investing in and supporting the development of technologies that enhance the removal of pharmaceutical residues from wastewater
Carefully consider nature-related impacts, dependencies, risks and opportunities when establishing new operations, taking water risks and proximity to areas of significant biodiversity value into account. Embed biodiversity and water risk assessment criteria into the decision-making process when selecting new sites or expansions and prioritize action according to conservation hierarchy in locations that meet the criteria